PIM1 and its downstream effector NFATc1 are enriched in the fibrotic foci of IPF lungs and their inhibition in IPF-derived lung fibroblasts in vitro and in human IPF lung explants ex vivo attenuated fibrogenic activation. This evidence concerns the gene PIM1 and idiopathic pulmonary fibrosis.